A Novel Treatment Strategy Utilizing Panobinostat for High-Risk and Treatment-Refractory Hepatoblastoma. Espinoza AF, Patel RH, Patel KR, Badachhape AA, et al. J Hepatol 2024 Jan 17:S0168-8278(24)00040-0. doi: 10.1016/j.jhep.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Espinoza AF, Patel RH, Patel KR, Badachhape AA, et al. A Novel Treatment Strategy Utilizing Panobinostat for High-Risk and Treatment-Refractory Hepatoblastoma. J Hepatol 2024 Jan 17:S0168-8278(24)00040-0. doi: 10.1016/j.jhep.2024.
PMID: 38242326